IRA Litigation: Pharma’s Failed Challenges To Medicare Drug Pricing

Forefront Group 2026 Dataset

View at publisher
Authors: Andrew J. Twinamatsiko, Sarah Wetter
DOI: 10.1377/forefront.20260311.767749
Cited by: 1

Abstract

To date, every court that has considered substantive challenges to the Medicare drug price negotiation program has ruled against the pharmaceutical industry, dismissing both constitutional and statutory arguments.

Publication details

Journal / source
Forefront Group
Publisher
Health Affairs Publishing, LLC
Publication date
13 March 2026
Document type
Dataset